ReWalk Robotics (NASDAQ:RWLK) Shares Pass Above Fifty Day Moving Average of $0.89

ReWalk Robotics Ltd. (NASDAQ:RWLKGet Rating)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.89 and traded as high as $0.94. ReWalk Robotics shares last traded at $0.94, with a volume of 262,144 shares traded.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on RWLK shares. HC Wainwright boosted their price objective on ReWalk Robotics from $2.50 to $3.00 and gave the stock a “buy” rating in a research report on Tuesday, November 15th. StockNews.com began coverage on shares of ReWalk Robotics in a research report on Monday, October 17th. They set a “sell” rating on the stock.

ReWalk Robotics Stock Up 6.6 %

The business has a fifty day simple moving average of $0.89 and a 200 day simple moving average of $0.95. The company has a market cap of $58.21 million, a price-to-earnings ratio of -3.24 and a beta of 2.39.

Insider Buying and Selling

In other news, major shareholder Global Fund Lp Lind II acquired 264,625 shares of ReWalk Robotics stock in a transaction dated Friday, November 11th. The shares were acquired at an average cost of $0.92 per share, with a total value of $243,455.00. Following the purchase, the insider now directly owns 4,807,228 shares of the company’s stock, valued at approximately $4,422,649.76. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last quarter, insiders purchased 570,286 shares of company stock worth $506,713. 0.78% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On ReWalk Robotics

A number of institutional investors have recently made changes to their positions in the business. Renaissance Technologies LLC grew its stake in ReWalk Robotics by 13.7% during the 3rd quarter. Renaissance Technologies LLC now owns 109,600 shares of the medical device company’s stock worth $97,000 after buying an additional 13,200 shares during the last quarter. Millennium Management LLC grew its stake in shares of ReWalk Robotics by 78.6% in the second quarter. Millennium Management LLC now owns 138,282 shares of the medical device company’s stock worth $130,000 after purchasing an additional 60,859 shares in the last quarter. Finally, Advisor Group Holdings Inc. grew its stake in shares of ReWalk Robotics by 12.2% in the first quarter. Advisor Group Holdings Inc. now owns 1,038,207 shares of the medical device company’s stock worth $1,204,000 after purchasing an additional 112,875 shares in the last quarter. 4.98% of the stock is owned by institutional investors and hedge funds.

About ReWalk Robotics

(Get Rating)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.

Recommended Stories

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.